Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial
2013 ◽
Vol 14
(12)
◽
pp. 1233-1242
◽
Keyword(s):
Phase 2
◽
2005 ◽
Vol 23
(16_suppl)
◽
pp. 8167-8167
◽